Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis

Growing evidence suggests that the gut microbiota is involved in the initiation and progression of ankylosing spondylitis (AS). In this study, we aimed to explore the gut microbiome alterations during adalimumab therapy and verify microbiome biomarkers predicting treatment response. By evaluating th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zena, Zheng, Xuqi, Wu, Xinyu, Wu, Jialing, Li, Xiaomin, Wei, Qiujing, Zhang, Xi, Fang, Linkai, Jin, Ou, Gu, Jieruo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441001/
https://www.ncbi.nlm.nih.gov/pubmed/34539629
http://dx.doi.org/10.3389/fimmu.2021.700570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441001/
https://www.ncbi.nlm.nih.gov/pubmed/34539629
http://dx.doi.org/10.3389/fimmu.2021.700570

Ejemplares similares